293 related articles for article (PubMed ID: 26546149)
1. Inhibition of TNF-α protects in vitro brain barrier from ischaemic damage.
Abdullah Z; Rakkar K; Bath PM; Bayraktutan U
Mol Cell Neurosci; 2015 Nov; 69():65-79. PubMed ID: 26546149
[TBL] [Abstract][Full Text] [Related]
2. NADPH oxidase mediates TNF-α-evoked in vitro brain barrier dysfunction: roles of apoptosis and time.
Abdullah Z; Bayraktutan U
Mol Cell Neurosci; 2014 Jul; 61():72-84. PubMed ID: 24907586
[TBL] [Abstract][Full Text] [Related]
3. Attenuation of urokinase activity during experimental ischaemia protects the cerebral barrier from damage through regulation of matrix metalloproteinase-2 and NAD(P)H oxidase.
Rakkar K; Srivastava K; Bayraktutan U
Eur J Neurosci; 2014 Jun; 39(12):2119-28. PubMed ID: 24649947
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of Rho-kinase protects cerebral barrier from ischaemia-evoked injury through modulations of endothelial cell oxidative stress and tight junctions.
Gibson CL; Srivastava K; Sprigg N; Bath PM; Bayraktutan U
J Neurochem; 2014 Jun; 129(5):816-26. PubMed ID: 24528233
[TBL] [Abstract][Full Text] [Related]
5. Hyperglycaemia promotes cerebral barrier dysfunction through activation of protein kinase C-β.
Shao B; Bayraktutan U
Diabetes Obes Metab; 2013 Nov; 15(11):993-9. PubMed ID: 23617822
[TBL] [Abstract][Full Text] [Related]
6. Suppression of PKC-α attenuates TNF-α-evoked cerebral barrier breakdown via regulations of MMP-2 and plasminogen-plasmin system.
Abdullah Z; Bayraktutan U
Biochim Biophys Acta; 2016 Jul; 1862(7):1354-66. PubMed ID: 27094771
[TBL] [Abstract][Full Text] [Related]
7. Small GTPase RhoA and its effector rho kinase mediate oxygen glucose deprivation-evoked in vitro cerebral barrier dysfunction.
Allen C; Srivastava K; Bayraktutan U
Stroke; 2010 Sep; 41(9):2056-63. PubMed ID: 20651275
[TBL] [Abstract][Full Text] [Related]
8. Outgrowth endothelial progenitor cells restore cerebral barrier function following ischaemic damage: The impact of NOX2 inhibition.
Alwjwaj M; Kadir RRA; Bayraktutan U
Eur J Neurosci; 2022 Mar; 55(6):1658-1670. PubMed ID: 35179812
[TBL] [Abstract][Full Text] [Related]
9. Increases in intracellular calcium perturb blood-brain barrier via protein kinase C-alpha and apoptosis.
Rakkar K; Bayraktutan U
Biochim Biophys Acta; 2016 Jan; 1862(1):56-71. PubMed ID: 26527181
[TBL] [Abstract][Full Text] [Related]
10. Retigabine protects the blood-brain barrier by regulating tight junctions between cerebral vascular endothelial cells in cerebral ischemia-reperfusion rats.
Zhao YJ; Nai Y; Li SY; Zheng YH
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8509-8518. PubMed ID: 30556894
[TBL] [Abstract][Full Text] [Related]
11. Microvascular endothelial cells-derived microvesicles imply in ischemic stroke by modulating astrocyte and blood brain barrier function and cerebral blood flow.
Pan Q; He C; Liu H; Liao X; Dai B; Chen Y; Yang Y; Zhao B; Bihl J; Ma X
Mol Brain; 2016 Jun; 9(1):63. PubMed ID: 27267759
[TBL] [Abstract][Full Text] [Related]
12. Geniposide protects against hypoxia/reperfusion-induced blood-brain barrier impairment by increasing tight junction protein expression and decreasing inflammation, oxidative stress, and apoptosis in an in vitro system.
Li C; Wang X; Cheng F; Du X; Yan J; Zhai C; Mu J; Wang Q
Eur J Pharmacol; 2019 Jul; 854():224-231. PubMed ID: 30995438
[TBL] [Abstract][Full Text] [Related]
13. Cysteinyl leukotriene receptor type 1 antagonist montelukast protects against injury of blood-brain barrier.
Zhou L; Sun X; Shi Y; Liu J; Luan G; Yang Y
Inflammopharmacology; 2019 Oct; 27(5):933-940. PubMed ID: 31313075
[TBL] [Abstract][Full Text] [Related]
14. TNF-α evokes blood-brain barrier dysfunction through activation of Rho-kinase and neurokinin 1 receptor.
Gao X; Bayraktutan U
Immunobiology; 2023 Sep; 228(5):152706. PubMed ID: 37454559
[TBL] [Abstract][Full Text] [Related]
15. Total Saponins of Panax Notoginseng Modulate the Astrocyte Inflammatory Signaling Pathway and Attenuate Inflammatory Injury Induced by Oxygen- Glucose Deprivation/Reperfusion Injury in Rat Brain Microvascular Endothelial Cells.
Wei X; Wen Y; Hu Y; Guo X
Curr Stem Cell Res Ther; 2024; 19(2):267-276. PubMed ID: 37218204
[TBL] [Abstract][Full Text] [Related]
16. Cilostazol attenuates ischemia-reperfusion-induced blood-brain barrier dysfunction enhanced by advanced glycation endproducts via transforming growth factor-β1 signaling.
Takeshita T; Nakagawa S; Tatsumi R; So G; Hayashi K; Tanaka K; Deli MA; Nagata I; Niwa M
Mol Cell Neurosci; 2014 May; 60():1-9. PubMed ID: 24472843
[TBL] [Abstract][Full Text] [Related]
17. Alteration in P-glycoprotein at the blood-brain barrier in the early period of MCAO in rats.
Cen J; Liu L; Li MS; He L; Wang LJ; Liu YQ; Liu M; Ji BS
J Pharm Pharmacol; 2013 May; 65(5):665-72. PubMed ID: 23600383
[TBL] [Abstract][Full Text] [Related]
18. Trilobatin attenuates cerebral ischaemia/reperfusion-induced blood-brain barrier dysfunction by targeting matrix metalloproteinase 9: The legend of a food additive.
Feng L; Li Y; Lin M; Xie D; Luo Y; Zhang Y; He Z; Gong Q; Zhun ZY; Gao J
Br J Pharmacol; 2024 Apr; 181(7):1005-1027. PubMed ID: 37723895
[TBL] [Abstract][Full Text] [Related]
19. Effect of magnolol on cerebral injury and blood brain barrier dysfunction induced by ischemia-reperfusion in vivo and in vitro.
Liu X; Chen X; Zhu Y; Wang K; Wang Y
Metab Brain Dis; 2017 Aug; 32(4):1109-1118. PubMed ID: 28378105
[TBL] [Abstract][Full Text] [Related]
20. Effects of Muscone on the Expression of P-gp, MMP-9 on Blood-Brain Barrier Model In Vitro.
Wang GY; Wang N; Liao HN
Cell Mol Neurobiol; 2015 Nov; 35(8):1105-15. PubMed ID: 25976179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
